Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 3558702

Single radial complement fixation test using NP-containing plates: a simple and sensitive method for the detection of influenza infection.

H Ochiai·M Shibata·S Sato·K Hayashi·S Niwayama
View original source ↗Export metadata ↓

Abstract

The single radial complement fixation (SRCF) test using nucleoprotein (NP) was compared with the haemagglutination inhibition (HAI) test in the course of the evaluation of the protective efficacy of influenza vaccine. In the case of persons who were not vaccinated, the percent incidence of infection was almost the same (which confirmed by HAI test or by SRCF test), whereas in the case of vaccinees, there was a significant difference between the incidence confirmed by HAI (7.9%) and SRCF (19.4%) tests. The SRCF test was shown to be a simple and sensitive method for detection of a significant rise in antibody titre against influenza virus.

Explore related subjects

Antibodies, ViralChildComplement Fixation TestsHemagglutination Inhibition TestsHumansInfluenza A virusInfluenza VaccinesInfluenza, HumanNucleocapsid ProteinsNucleoproteinsViral Core ProteinsComparative StudyJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

H Ochiai, M Shibata, S Sato, K Hayashi, S Niwayama. 1987. Single radial complement fixation test using NP-containing plates: a simple and sensitive method for the detection of influenza infection.. https://doi.org/10.1016/0166-0934(87)90058-9

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2001

Sabin monovalent oral polio vaccines: review of past experiences and their potential use after polio eradication.

After global eradication of polio is achieved, there will be a need for stockpiles of vaccine to combat potential outbreaks of poliomyelitis caused by (1) unforeseen release of polioviruses, (2) continued circulation of vaccine-derived strains, or (3) prolonged replication of polioviruses in immunodeficient persons. We conducted a review of the literature to document the immunogenicity and safety of monovalent Sabin vaccines, considered ideal candidates for these situations. The National Library of Medicine archives were searched for the keywords "polio," "monovalent," and "vaccine." Seroconversion rates for monovalent Sabin type 1 ranged from 53% to 100% (median, 95%); for type 2, 77%-100% (median, 93%); and for type 3, 52%-100% (median, 85%). The risk of vaccine-associated poliomyelitis per million persons vaccinated ranged from.05 to 0.99 (type 1), 0-0.65 (type 2), and 1.18-8.91 (type 3). Single-dose monovalent Sabin vaccines are highly immunogenic and safe and should be considered for stockpiles of vaccine to provide an effective response to potential outbreaks of poliomyelitis in the post-eradication period.

Antibodies, Viral↗
PubMed2001

A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology.

An enzyme-linked immunosorbent assay (ELISA) system has been developed that uses glutathione crosslinked to casein as capture protein to bind recombinant protein antigens fused to N-terminal glutathione S-transferase (GST). The method allows simple and efficient immobilization and one-step purification of overexpressed recombinant antigens from crude lysates on ELISA plates coated with glutathione casein. Several antigens can be tested in parallel under the same conditions without the need to biochemically purify or renature the proteins. An additional undecapeptide epitope fused to the C-terminus of each antigen permits the detection and quantification of any full-length protein antigen bound to the ELISA plate with one single monoclonal antibody. The ELISA system was applied with four antigens to detect antibodies against E6 and E7 proteins of human papillomavirus types 16 and 18. Antibody reactivities of 164 sera from patients with cervical carcinoma and healthy individuals were in good agreement with those determined using a previously established capture ELISA with biochemically purified and renatured proteins as antigens although the GST capture ELISA was more sensitive with no loss of specificity. The GST capture ELISA could be adapted to provide standardized antibody assays for many protein antigens.

Antibodies, Viral↗